Key facts
- Notable investors include Juxtapose.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Aperture
- ·The full record, as it builds
Funding rounds
No funding rounds for Aperture are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aperture
Developer of clinical research site networks designed to address patient recruitment challenges in clinical trials. The company's platform integrates AI-driven recruitment tools, physician sites, and embeds research into routine care workflows, enabling clinical trial sponsors and healthcare providers to reduce recruitment delays, data quality, and access to underserved populations through a physician-centric model that standardizes operations across fragmented sites.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Ownership
- Privately Held (backing)
Aperture doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aperture shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aperture in its N-PORT filings yet. We sweep new filings monthly.